We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Oral Administration of Poly-γ-Glutamate Ameliorates Atopic Dermatitis in Nc/Nga Mice by Suppressing Th2-Biased Immune Response and Production of IL-17A.
- Authors
Lee, Tae-Young; Kim, Doo-Jin; Won, Ji-Na; Lee, Il-Han; Sung, Moon-Hee; Poo, Haryoung
- Abstract
Atopic dermatitis (AD) is a chronic inflammatory skin disease that is closely related to dysregulation of the T helper type 1 and 2 (Th1)/Th2 balance. A previous study showed that high molecular mass poly-γ-glutamate (γ-PGA) isolated from Bacillus subtilis sp. Chungkookjang induces the production of IL-12 from dendritic cells (DCs). Here, we investigated the effect of γ-PGA on AD-like skin disease using an Nc/Nga mouse model. In vitro, γ-PGA activated DCs and induced IL-12 production in mice. In vivo, oral administration of γ-PGA markedly reduced the AD symptoms, similar to the response seen in the dexamethasone (Dex)-treated group. Treatment with γ-PGA also decreased the serum levels of IgG1, the skin levels of Th2 cytokines, the extent of skin inflammation, and the accumulation of mast cells. Furthermore, γ-PGA was effective against established AD, significantly decreasing serum IgE and Th2 cytokines in the inflamed tissue. Interestingly, the production of IL-17A in splenocytes was also suppressed by γ-PGA, indicating that it inhibits both Th2 and Th17 immune responses. Collectively, these results suggest that oral administration of γ-PGA could be a therapeutic strategy for treating AD via the modulation of Th2-biased immune responses in an Nc/Nga mouse model.
- Subjects
DRUG administration; GLUTAMIC acid; ATOPIC dermatitis; IMMUNE response; INTERLEUKIN-17; SKIN inflammation; LABORATORY mice
- Publication
Journal of Investigative Dermatology, 2014, Vol 134, Issue 3, p704
- ISSN
0022-202X
- Publication type
Article
- DOI
10.1038/jid.2013.389